Skip to content
Metabolic peptides

Retatrutide

Retatrutide is an investigational lipidated peptide that acts at the GIP, GLP-1 and glucagon receptors. Approved business buyers can apply for wholesale access.

US Peptide Distributors supplies Retatrutide at wholesale to approved business buyers in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg and 60mg vials, from USA stock with same-day shipping and overseas-sourced supply (typically 7-10 days). Every lot is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. There is no minimum order on USA stock. Pricing is quoted by supply option and tiered by volume.

Updated

Synonyms
LY3437943
Vial sizes5mg10mg15mg20mg30mg40mg60mg

Approved buyers see pricing

Wholesale pricing is available to approved business buyers after they log in.

Supply and testing

  • Every lot third-party testedHPLC for purity, mass spectrometry for identity. Labs: Freedom Diagnostics and ILS Labs.
  • Three supply optionsSupply options for wholesale ordersUSA stock (ships from US inventory), USA-synthesized, overseas-sourced.Ask which options apply to this compound.
  • Same-day shipping on USA stockExpedited options available. Overseas-sourced orders typically take 7-10 days.
  • No minimum on USA stockOne box to thousands of kits, plus gram and kilogram powder.
  • COA in your company nameCan be added to an order and is provided with it.

Distributor programShipping times

Request a quote for Retatrutide

A three-receptor peptide

Retatrutide, known in the literature by the code LY3437943, is described in a 2026 review as an investigational, lipidated peptide of 39 residues. What sets it apart is its receptor profile. It activates three receptors at once: the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor and the glucagon receptor. The review uses the term unimolecular poly-agonism for this approach, in which one molecule carries all three activities instead of being assembled from separate agents.

Receptor signaling in isolated tissue

Because all three receptors signal through cyclic AMP, a group at Martin Luther University Halle-Wittenberg tested whether retatrutide would behave like a beta-adrenoceptor agonist in isolated mouse atria. It did not increase force of contraction in left atrial preparations. It did raise the beating rate in right atrial preparations. That rate response was reduced by a glucagon receptor antagonist and by an inhibitor of protein kinase A, and it was blocked by activating muscarinic or adenosine A1 receptors. The authors concluded that the rate effect runs through the glucagon receptor, cAMP and PKA, and that retatrutide and isoprenaline may raise cAMP in different compartments of the sinus node. This is a pharmacology experiment in mouse tissue, not a statement about people.

Pharmaceutical development questions

The review also lists the practical issues that follow from a long lipidated peptide: scalable synthesis, impurity and potency control, formulation stability, immunogenicity and reliable delivery. For anyone sourcing material, the first two matter most. A 39-residue chain with a lipid side chain has many places where truncations, deletions or side-chain variants can arise, and intact-mass measurement is the usual way to check for them.

Research status

Retatrutide has been the subject of clinical trials, and the 2026 review notes that only one phase 3 trial has a full peer-reviewed report so far. We do not summarize trial outcomes on this page. Our scope here is molecular identity, class and mechanism research.

Supply is for approved business buyers, for laboratory research use only.

References

  1. Mateescu DM, et al. Retatrutide as a Unimolecular GIP/GLP-1/Glucagon Receptor Tri-Agonist: Molecular Design, Pharmaceutical Development and Critical Interpretation of Emerging Phase 3 Evidence. Pharmaceutics. 2026.
  2. Neumann J, et al. Contractile effects of retatrutide in isolated mouse atrial preparations. Naunyn Schmiedebergs Arch Pharmacol. 2025.

Questions

Is retatrutide an approved drug?

No. Retatrutide is investigational and is not an approved drug.

Where can I find retatrutide wholesale pricing?

Pricing is shown only to approved business accounts after login. Lot COAs, where uploaded, appear on the compound page.

Where can I buy Retatrutide in bulk?

US Peptide Distributors supplies Retatrutide to approved business buyers in 5mg, 10mg, 15mg, 20mg, 30mg, 40mg and 60mg vials, from USA stock with same-day shipping and overseas-sourced supply (typically 7-10 days). Apply for a buyer account to see wholesale pricing; larger volumes are quoted on request.

How much does Retatrutide cost wholesale?

US Peptide Distributors shows wholesale pricing for Retatrutide to approved business accounts after login. Pricing is quoted by supply option and tiered by volume, so the per-box price falls as the box count rises.

What is retatrutide chemically?

Retatrutide (code LY3437943) is a lipidated peptide of 39 residues described as a GIP, GLP-1 and glucagon receptor tri-agonist.

Is retatrutide sold for use in humans?

No. It is sold to approved business buyers for laboratory research use only, not for use in humans.

Can I buy Retatrutide from a US supplier?

Yes. US Peptide Distributors holds Retatrutide in USA stock, which ships from US inventory with same-day shipping and expedited options available. There is no minimum order on USA stock.

Is each lot of Retatrutide third-party tested?

Yes. Every lot US Peptide Distributors supplies is tested by an independent third-party laboratory (we use Freedom Diagnostics and ILS Labs): HPLC for purity and mass spectrometry for identity. Lot COAs appear on this page as they are uploaded.